CPG23PANC

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCPG23PANC

Drug Alias Namedendritic cell therapy vaccine (Celprogen)CPG23PANC

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineBiologics > Antigen > Tumor antigen +[5]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelprogen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCelprogen

Active IndicationsN/A

Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A